
Medrel Pharmaceuticals (India) Private Limited
About Medrel Pharmaceuticals (India) Private Limited
Data last updated:
Medrel Pharmaceuticals (India) Private Limited is a private limited company based in Mumbai, Maharashtra, India. The company is currently under liquidation, meaning its assets are being sold to settle outstanding debts. It may not have the legal capacity to fulfil new contracts. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 August 1998.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1998PTC116233.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Akshay Girjashankar Mehta and Mona Akshay Mehta.
Its last annual general meeting (AGM) was held on 30 September 2010, and its latest financial statements are for the year ended 31 March 2010. The registered office is at 54 – B Drug Houseprocter Road, Mumbai, Maharashtra, India – 400007.
As per MCA filings, the company has open charges of ₹2.5 Lakh on record. Court records list 10 cases involving the company, including 10 filed against it; 1 case is pending.
Company details
Contact details
Medrel Pharmaceuticals (India) Private Limited's registered office is in Mumbai, Maharashtra.
- Registered Address54 – B Drug Houseprocter Road, Mumbai, Maharashtra, India – 400007
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Medrel Pharmaceuticals (India) Private Limited
FY 2010 filings availableFinancial Statement Summary
| Metrics | FY 2009-10 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2009-10 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Medrel Pharmaceuticals (India) Private Limited, buy the company report.
Board of directors of Medrel Pharmaceuticals (India) Private Limited
Medrel Pharmaceuticals (India) has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Akshay Girjashankar Mehta | Director | 13 Aug 1998 | 28 Years 3 Months | As last reported |
| Mona Akshay Mehta | Director | 13 Aug 1998 | 28 Years 3 Months | As last reported |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Apr 2004 | 90149522 | Citi Bank N a | ₹2.5 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Medrel Pharmaceuticals (India) Private Limited has 10 court cases on record: 10 filed against it. 1 case is pending and 9 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 8 | 1 |
| High courts | 2 | 2 | 0 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Company petition | Filed against the company by Mak Ampoules Private Ltd. | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (SUMMONS CASES SS) | Filed against the company by an individual | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Interim or miscellaneous application | Filed against the company by an individual | Disposed |
| Bombay High Court | Appeal | Filed against the company by an individual | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Court case (CHAMBER SUMMONS) | Filed against the company by an individual | Disposed |
To see the full case history of Medrel Pharmaceuticals (India) Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medrel Pharmaceuticals (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Medrel Pharmaceuticals (India) Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Medrel Pharmaceuticals (India) Private Limited has 2 board changes on record since 1998: 2 appointments. The latest: Akshay Girjashankar Mehta was appointed as Director on 13 Aug 1998.
Frequently asked questions
Medrel Pharmaceuticals (India) is currently "Under Liquidation" as per MCA records. The company's assets are being sold to settle outstanding debts owed to creditors. A company under liquidation may not have the legal capacity to fulfil new contracts, and creditors are prioritised in the distribution of proceeds. This is a high-risk status - caution is strongly advised.
Medrel Pharmaceuticals (India) is a company under liquidation, formerly operating as a private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 August 1998 and is registered under CIN U24230MH1998PTC116233. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Medrel Pharmaceuticals (India) has 2 current directors:
- Akshay Girjashankar Mehta - Director
- Mona Akshay Mehta - Director
The latest financial statements of Medrel Pharmaceuticals (India) on record with the MCA are for the year ended 31 March 2010. Its last annual general meeting was held on 30 September 2010. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Medrel Pharmaceuticals (India) is U24230MH1998PTC116233. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medrel Pharmaceuticals (India) has open charges of ₹2.5 Lakh and no satisfied charges on record as per latest MCA filings.
Medrel Pharmaceuticals (India) has 10 court cases on record: 10 filed against it. 1 is pending. Most are in the district courts.
Medrel Pharmaceuticals (India) was incorporated on 13 August 1998. It is registered with the Registrar of Companies, Mumbai.
Akshay Girjashankar Mehta was appointed as Director on 13 Aug 1998. Mona Akshay Mehta was appointed as Director on 13 Aug 1998.
The registered office of Medrel Pharmaceuticals (India) is at 54 – B Drug Houseprocter Road, Mumbai, Maharashtra, India – 400007.

